Table 3:

Relative risk of advanced melanoma from modified Poisson regression, including results stratified by ulceration status

VariableUnstratified unadjusted modelUnstratified adjusted model*Stratified adjusted model
Ulceration absentUlceration present
RR (95% CI)
n = 8042
RR: No interactions (95% CI)
n = 8042
RR (95% CI)
n = 6581
RR (95% CI)
n = 1461
Patient factors
Sex
 Male1.38 (1.28–1.49)1.12 (1.05–1.20)1.14 (1.01–1.27)1.08 (1.02–1.14)
 Female1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
Age
 20–45 yr0.67 (0.57–0.78)0.83 (0.73–0.94)0.75 (0.61–0.93)1.01 (0.90–1.14)
 46–55 yr0.87 (0.76–0.99)0.97 (0.87–1.09)0.92 (0.77–1.12)1.04 (0.94–1.16)
 56–65 yr1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 66–75 yr1.20 (1.07–1.36)1.13 (1.03–1.25)1.13 (0.95–1.34)1.08 (0.98–1.18)
 76–85 yr1.66 (1.48–1.85)1.27 (1.16–1.40)1.40 (1.19–1.64)1.15 (1.05–1.25)
 >85 yr2.38 (2.10–2.69)1.53 (1.37–1.72)2.04 (1.68–2.49)1.26 (1.16–1.37)
Deprivation
 Least deprived1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 Quintile 21.11 (0.99–1.23)1.05 (0.96–1.15)0.99 (0.85–1.16)1.05 (0.97–1.13)
 Quintile 31.24 (1.11–1.38)1.12 (1.02–1.23)1.24 (1.05–1.46)1.03 (0.95–1.12)
 Quintile 41.31 (1.17–1.48)1.14 (1.03–1.26)1.19 (1.00–1.41)1.01 (0.91–1.10)
 Most deprived1.53 (1.35–1.74)1.24 (1.12–1.38)1.31 (1.08–1.58)1.10 (1.01–1.20)
 Missing0.39 (0.29–0.52)0.56 (0.44–0.71)0.40 (0.26–0.63)1.01 (0.83–1.22)
Health-system factors
LHIN
 LHIN A0.73 (0.62–0.87)1.04 (0.90–1.19)0.88 (0.69–1.14)1.06 (0.94–1.19)
 LHIN B0.78 (0.65–0.92)1.08 (0.94–1.25)1.04 (0.82–1.33)1.06 (0.94–1.19)
 LHIN C0.80 (0.68–0.94)1.09 (0.95–1.24)0.99 (0.79–1.25)0.99 (0.88–1.12)
 LHIN D0.82 (0.67–1.00)1.00 (0.86–1.18)0.76 (0.53–1.09)1.06 (0.93–1.21)
 LHIN E0.83 (0.72–0.97)1.10 (0.97–1.24)0.99 (0.79–1.24)1.08 (0.98–1.20)
 LHIN F0.85 (0.71–1.01)1.09 (0.94–1.26)0.98 (0.76–1.27)1.06 (0.94–1.20)
 LHIN G0.87 (0.73–1.04)0.92 (0.79–1.07)0.83 (0.65–1.06)0.90 (0.78–1.03)
 LHIN H0.87 (0.76–1.01)1.05 (0.93–1.18)0.95 (0.76–1.18)1.06 (0.96–1.17)
 LHIN I0.92 (0.77–1.09)1.04 (0.91–1.19)0.97 (0.75–1.27)1.04 (0.93–1.16)
 LHIN J0.92 (0.66–1.28)1.20 (0.91–1.58)1.15 (0.70–1.90)1.07 (0.86–1.33)
 LHIN K0.93 (0.75–1.15)1.15 (0.96–1.38)1.02 (0.77–1.36)1.04 (0.88–1.23)
 LHIN L1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 LHIN M1.07 (0.91–1.26)1.34 (1.16–1.54)1.33 (1.04–1.70)1.15 (1.03–1.29)
 LHIN N1.09 (0.91–1.30)1.27 (1.09–1.47)1.25 (0.95–1.64)1.13 (1.01–1.26)
Rurality§
 Major urban1.00 (ref)
 Non-major urban0.95 (0.87–1.03)
 Rural1.02 (0.91–1.16)
 Missing data0.34 (0.25–0.45)
Disease factors
Histology
 Superficial1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 Acral3.76 (3.11–4.53)2.15 (1.83–2.52)2.52 (1.62–3.92)1.40 (1.23–1.59)
 Lentigo maligna0.69 (0.53–0.88)0.67 (0.52–0.85)0.63 (0.45–0.87)0.86 (0.63–1.18)
 Nodular5.72 (5.22–6.27)2.84 (2.57–3.15)6.60 (5.71–7.64)1.45 (1.33–1.59)
 NOS1.39 (1.23–1.56)1.29 (1.16–1.44)1.33 (1.12–1.58)1.16 (1.04–1.29)
 Other4.01 (3.52–4.57)2.79 (2.45–3.18)4.82 (3.97–5.87)1.36 (1.21–1.52)
Body site
 Extremities1.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 Head and neck1.58 (1.39–1.79)1.17 (1.05–1.30)1.36 (1.13–1.63)1.05 (0.96–1.14)
 Face1.03 (0.92–1.17)0.97 (0.87–1.08)1.05 (0.88–1.26)0.92 (0.83–1.01)
 Trunk0.98 (0.90–1.07)0.97 (0.90–1.05)0.96 (0.84–1.10)1.00 (0.93–1.06)
 Unspecified1.37 (1.15–1.63)1.22 (1.05–1.42)1.29 (1.01–1.66)1.08 (0.95–1.23)
Ulceration
 Present5.53 (5.18–5.90)3.22 (2.97–3.49)
 Absent1.00 (ref)1.00 (ref)
  • Note: CI = confidence interval, LHIN = local health integration network, NOS = not otherwise specified, ref = reference, RR = relative risk.

  • * Controlled for sex, age, deprivation, LHIN, histology, site and ulceration.

  • Controlled for sex, age, deprivation, LHIN, histology and site.

  • Variable that had a significant interaction with ulceration.

  • § Rurality was not included in the adjusted model.